Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumour of Epithelial Origin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04620954
What this trial is testing

Clinical Trial of Chemotherapy, Oregovomab and Nivolumab in Patients With Epithelial Cancer of Ovarian, Tubal or Peritoneal Origin

Who this might be right for
Epithelial Ovarian Cancer
National Cancer Centre, Singapore 31
Testing effectiveness (Phase 2)Study completedNCT02028442
What this trial is testing

Phase I / II Study of Enadenotucirev by Sub-acute Fractionated IV Dosing in Cancer Patients

Who this might be right for
Solid Tumours of Epithelial OriginMetastatic Colorectal CancerMetastatic Bladder Cancer
Akamis Bio 61
Early research (Phase 1)Looking for participantsNCT07517198
What this trial is testing

Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors

Who this might be right for
Solid TumorSmall Cell Lung Cancer (SCLC)High Grade Neuroendocrine Cancer+9 more
Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. 40
Early research (Phase 1)Ended earlyNCT00481936
What this trial is testing

Study of the Safety of VB6-845 in Patients With Advanced Solid Tumours of Epithelial Origin

Who this might be right for
Neoplasms, Glandular and Epithelial
Sesen Bio, Inc. 15
Not applicableStudy completedNCT02966509
What this trial is testing

Engagement of Patients With Advanced Cancer

Who this might be right for
End of LifeAdvanced CancerLung Neoplasm+11 more
Stanford University 213
Very early researchStudy completedNCT02728830
What this trial is testing

Pembrolizumab on the Tumoral Immunoprofile of Gynecologic Cancers

Who this might be right for
Gynecologic NeoplasmsEpithelial Ovarian CancerUterine Endometrial Cancer+2 more
AA Secord 39
Not applicableLooking for participantsNCT06725173
What this trial is testing

Detailed Phenotypic and Genotype Study to Correlate RB1 Mutations Relating to Primary Ocular Tumors and Secondary Extra-ocular Metastasis.

Who this might be right for
Retinoblastoma BilateralRetinoblastoma UnilateralRetinoblastoma, Extraocular+2 more
University of Washington 100
Large-scale testing (Phase 3)UnknownNCT00392886
What this trial is testing

Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
Children's Hospital Los Angeles 120
Not applicableStudy completedNCT04823468
What this trial is testing

Effect of Oral Nutritional Supplements on Body Weight Loss of Patients With Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaNutritional Support
Jinsheng Hong 236
Large-scale testing (Phase 3)Ended earlyNCT00050375
What this trial is testing

Clinical Trial for Ovarian Cancer (OvaRex®)

Who this might be right for
Ovarian Cancer
Unither Pharmaceuticals 354
Early research (Phase 1)Study completedNCT01031784
What this trial is testing

Radioactive Holmium Microspheres for the Treatment of Liver Metastases

Who this might be right for
Liver MetastasisLiver Tumors
UMC Utrecht 15
Testing effectiveness (Phase 2)Ended earlyNCT03100006
What this trial is testing

Phase Ib/IIa Trial to Evaluate Oregovomab and Nivolumab in Epithelial Cancer of Ovarian, Tubal or Peritoneal Origin

Who this might be right for
Epithelial Ovarian Cancer
National Cancer Centre, Singapore 13
Not applicableWithdrawnNCT01191385
What this trial is testing

GIDEON Non-Nexavar Arm - HCC Patients Who Are Treated With Any Therapy Other Than Nexavar at Individual Study Start

Who this might be right for
Carcinoma, Hepatocellular
Bayer
Not applicableStudy completedNCT00937989
What this trial is testing

Study of Barriers to Beginning and Finishing Treatment for Patients With Breast Cancer

Who this might be right for
Breast Cancer
City of Hope Medical Center 52
Early research (Phase 1)Study completedNCT00004082
What this trial is testing

Combination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial Tumors

Who this might be right for
Endometrial CancerFallopian Tube CancerOvarian Cancer+1 more
Beth Israel Deaconess Medical Center
Testing effectiveness (Phase 2)Study completedNCT00068237
What this trial is testing

Salivary Gland Surgery Before Radiation Therapy in Preventing Radiation-Caused Xerostomia in Patients With Head and Neck Cancer

Who this might be right for
Head and Neck CancerRadiation ToxicityXerostomia
Radiation Therapy Oncology Group 49
Early research (Phase 1)Study completedNCT00055614
What this trial is testing

Topotecan in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Beth Israel Deaconess Medical Center 20
Testing effectiveness (Phase 2)WithdrawnNCT02017678
What this trial is testing

Phase 2 Study of JX-594 in Patients With Peritoneal Carcinomatosis of Ovarian Cancer Origin

Who this might be right for
Ovarian Cancer
Andrea McCart
Testing effectiveness (Phase 2)Ended earlyNCT00086632
What this trial is testing

Study of Ovarex® (Oregovomab) MAb With Front-Line Chemotherapy for Ovarian Cancer Treatment

Who this might be right for
Ovarian Cancer
Unither Pharmaceuticals 40
Large-scale testing (Phase 3)Looking for participantsNCT07195591
What this trial is testing

Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care

Who this might be right for
Glioblastoma
GT Medical Technologies, Inc. 766
Next Page